APA (7th ed.) Citation

Nirogi, R., Abraham, R., Jayarajan, P., Goura, V., Kallepalli, R., Medapati, R. b., . . . Jasti, V. (2022). Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: Pharmacological, behavioral, and neurochemical characterization. Psychopharmacology, 239(7), 2215. https://doi.org/10.1007/s00213-022-06108-6

Chicago Style (17th ed.) Citation

Nirogi, Ramakrishna, et al. "Ropanicant (SUVN-911), an α4β2 Nicotinic Acetylcholine Receptor Antagonist Intended for the Treatment of Depressive Disorders: Pharmacological, Behavioral, and Neurochemical Characterization." Psychopharmacology 239, no. 7 (2022): 2215. https://doi.org/10.1007/s00213-022-06108-6.

MLA (9th ed.) Citation

Nirogi, Ramakrishna, et al. "Ropanicant (SUVN-911), an α4β2 Nicotinic Acetylcholine Receptor Antagonist Intended for the Treatment of Depressive Disorders: Pharmacological, Behavioral, and Neurochemical Characterization." Psychopharmacology, vol. 239, no. 7, 2022, p. 2215, https://doi.org/10.1007/s00213-022-06108-6.